Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 426, pseudogene (RN7SL426P) is classified as a **pseudogene** of the 7SL RNA, a key non-coding RNA that functions as a component of the signal recognition particle, but RN7SL426P lacks protein-coding capability and is not known to be expressed or functional[1][5][6][7]. Pseudogenes like RN7SL426P typically result from duplication or retrotransposition events and are considered non-functional "genomic fossils"; most 7SL RNA pseudogenes are truncated and are not thought to contribute to cellular pathways or act as receptors, enzymes, or therapeutic targets[5][6][7]. There is currently no evidence that RN7SL426P is involved in disease, drug interaction, or has biomarker or safety relevance[1][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 426, pseudogene (RN7SL426P).